These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8390727)

  • 1. The future of therapy for glioblastoma.
    Kornblith PK; Welch WC; Bradley MK
    Surg Neurol; 1993 Jun; 39(6):538-43. PubMed ID: 8390727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
    Parvez T
    Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral vector: potential therapeutic for glioblastoma multiforme.
    Manikandan C; Kaushik A; Sen D
    Cancer Gene Ther; 2020 May; 27(5):270-279. PubMed ID: 31316136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.
    Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Hassan SSU
    Biomed Pharmacother; 2017 Aug; 92():681-689. PubMed ID: 28582760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral therapy for glioblastoma.
    Chiocca EA; Aghi M; Fulci G
    Cancer J; 2003; 9(3):167-79. PubMed ID: 12952302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral vectors as therapeutic agents for glioblastoma.
    Aghi M; Rabkin S
    Curr Opin Mol Ther; 2005 Oct; 7(5):419-30. PubMed ID: 16248277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Perspectives in Glioblastoma: Nanoparticles-based Approaches.
    Luciano R; Battafarano G; Saracino R; Rossi M; Perrotta A; Manco M; Muraca M; Del Fattore A
    Curr Cancer Drug Targets; 2017; 17(3):203-220. PubMed ID: 27528362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma multiforme: Pathogenesis and treatment.
    Alifieris C; Trafalis DT
    Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant astrocytic gliomas in children.
    Marchese MJ; Chang CH
    Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of immunotherapy and gene therapy for high-grade gliomas.
    Marsh JC; Goldfarb J; Shafman TD; Diaz AZ
    Cancer Control; 2013 Jan; 20(1):43-8. PubMed ID: 23302906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions.
    Corso CD; Bindra RS
    Semin Radiat Oncol; 2016 Oct; 26(4):281-98. PubMed ID: 27619250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.
    Parney IF; Petruk KC; Zhang C; Farr-Jones M; Sykes DB; Chang LJ
    Hum Gene Ther; 1997 Jun; 8(9):1073-85. PubMed ID: 9189765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for glioblastoma.
    Aghi M; Chiocca EA
    Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional and gene therapy strategies for the treatment of brain tumors.
    Benítez JA; Domínguez-Monzón G; Segovia J
    Curr Med Chem; 2008; 15(8):729-42. PubMed ID: 18393842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapeutic options in therapy of glioblastoma multiforme].
    Lakomý R; Burkon P; Burkonová D; Jancálek R
    Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune and viral therapies for malignant primary brain tumors.
    Gardeck AM; Sheehan J; Low WC
    Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
    Batash R; Asna N; Schaffer P; Francis N; Schaffer M
    Curr Med Chem; 2017; 24(27):3002-3009. PubMed ID: 28521700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of glioblastoma by direct inoculation of concentrated high titer-recombinant retrovirus carrying the herpes simplex virus thymidine kinase gene.
    Ikenaka K; Sasaki M; Tamura K; Tamura M; Miyao Y; Nanmoku K; Kawano Y; Nakahira K; Yoshimine T; Shimizu K
    Hum Cell; 2001 Mar; 14(1):49-58. PubMed ID: 11436353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.
    Rainov NG
    Hum Gene Ther; 2000 Nov; 11(17):2389-401. PubMed ID: 11096443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.